Related Experiment Video
Updated: Jun 12, 2026
11:04
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Future of oncologic photodynamic therapy.
Ron R Allison1, Vanderlei S Bagnato, Claudio H Sibata
121st Century Oncology, 801 WH Smith Blvd, Greenville, NC 27834, USA. rallison@rtsx.com
Future Oncology (London, England)
|June 10, 2010
Summary
Photodynamic therapy (PDT) offers a tumor-ablative, function-sparing cancer treatment. While effective for various tumors, ongoing research aims to improve photosensitizers and light sources for enhanced oncologic PDT outcomes.
Area of Science:
- Oncology
- Photochemistry
Background:
- Photodynamic therapy (PDT) is an established oncologic intervention utilizing photosensitizers and light to induce tumor cell death and vascular damage.
- Its relative simplicity and demonstrated efficacy in clinical trials have led to widespread adoption for cutaneous and deep tissue tumors.
Purpose of the Study:
- To review the current status of photodynamic therapy in oncology.
- To identify the limitations of existing photosensitizers and light sources.
- To highlight advancements and future directions for optimizing oncologic PDT.
Main Methods:
- Review of current literature on photodynamic therapy.
- Analysis of clinical trial data demonstrating PDT efficacy.
- Discussion of limitations in current photosensitizer and light source technology.
Main Results:
- PDT is a proven effective treatment for various tumors, offering tumor ablation and function preservation.
- Commercially available photosensitizers and established light sources have enabled successful clinical applications worldwide.
- Current limitations exist in photosensitizer and light source technology that require further development.
Conclusions:
- Photodynamic therapy is a valuable oncologic treatment with a growing global presence.
- Future advancements in therapeutic agents and illumination devices are expected to refine and enhance PDT efficacy.
- Continued research is crucial for overcoming current limitations and realizing the full potential of oncologic PDT.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...